Nilsson I M, Jonsson S, Sundqvist S B, Ahlberg A, Bergentz S E
Blood. 1981 Jul;58(1):38-44.
A 37-yr-old hemophiliac with factor IX antibody in high titer required operation for a pseudotumor growing invasively into the bone in his left elbow. Exchange plasma-pheresis was not feasible, mainly because of possible stimulation of factor IX inhibitor. In addition, the patient had antibodies against tissue antigens. The factor IX antibodies were of IgG type and adsorbable to protein-A-agarose. The antibodies were removed by extracorporeal adsorption of the plasma (separated intermittently in a cell centrifuge) to sterile protein-A-Sepharose in columns, operated by a computer. The treated plasma was retransfused. In this manner, a total of 6000 ml of plasma was depleted of antibodies, and the antibody titer, as well as the total immunoglobulin content, decreased to one-fifth of the original values. The remaining antibodies were neutralized by infusion of factor IX concentrate. Conventional substitution therapy, in combination with immunosuppression, was then possible. The operation was performed without complications. No signs of hemolysis, complement activation, or activation of the coagulation system occurred. In principle, the same form of treatment can be used in patients with other forms of antibodies.
一名37岁的血友病患者,其IX因子抗体效价很高,因左肘部有一侵袭性生长至骨内的假肿瘤而需要手术。置换血浆单采术不可行,主要是因为可能会刺激IX因子抑制剂。此外,该患者还有针对组织抗原的抗体。IX因子抗体为IgG型,可吸附于蛋白A琼脂糖。通过计算机操作,将血浆(在细胞离心机中间歇分离)体外吸附到无菌蛋白A琼脂糖柱上,从而去除抗体。处理后的血浆再回输。通过这种方式,总共6000毫升血浆中的抗体被清除,抗体效价以及总免疫球蛋白含量降至原值的五分之一。剩余抗体通过输注IX因子浓缩物进行中和。然后可以进行传统的替代疗法并联合免疫抑制。手术顺利进行,未出现溶血、补体激活或凝血系统激活的迹象。原则上,相同的治疗方式可用于患有其他形式抗体的患者。